IPO · TLIS
Talis Biomedical Corp
Formerly SlipChip Corp
Talis Biomedical Corp (TLIS) priced its initial public offering on Feb 12, 2021 at $16.00 per share, within its $14.00–$16.00 range, raising $220.8M, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $853.5M. Cooley advised the company and Latham & Watkins advised the underwriters.
- Status
- IPO
- Ticker
- TLIS
- Exchange
- Nasdaq Global Market
- Priced
- Feb 12, 2021
- IPO price
- $16.00
- Price range
- $14.00–$16.00
- Raised
- $220.8M
- Market cap at IPO price
- $853.5M
- First filed
- Jan 22, 2021
- Company counsel
- Cooley
- Underwriters' counsel
- Latham & Watkins
- Sector
- Industrials & materials
- Country / state
- IL
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
- Analyst notes on the filing
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Jan 22, 2021
- Latest amendment Feb 11, 2021
- Final prospectus (424B4) Feb 12, 2021
- All filings on EDGAR CIK 1584751
Other Industrials & materials IPOs in 2021
- Hayward Holdings, Inc.HAYW · Mar 15, 2021
- E-Power Inc.SDH · Feb 11, 2021 · $26.9M
- Atotech LtdATC · Feb 5, 2021 · $497.6M
- CN Energy Group. Inc.CNEY · Feb 5, 2021 · $20M
- EZGO Technologies Ltd.EZGO · Jan 25, 2021 · $11.2M
- Huadi International Group Co., Ltd.HUDI · Jan 22, 2021 · $25M